The HEPLISAV-B brand, founded in 2013 (United States), from 5 sister brands and 4959 competing brands. The HEPLISAV-B brand is owned by Dynavax Technologies Co., a company listed in New York. The sector of HEPLISAV-B is Drug Manufacturers.
Share price and profitability of the share Dynavax Technologies Co. (HEPLISAV-B)
Buy Dynavax Technologies Co. share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Dynavax Technologies Co.
(HEPLISAV-B)
over 5 years*
USD 30.03
Stock market history Dynavax Technologies Co. (HEPLISAV-B)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
